Ray Dalio acquired 126 Thousand Sarepta Therapeutics shares worth $13.8 Million. That's 0.06% of their equity portfolio (256th largest holding). The first Sarepta Therapeutics trade was made in Q1 2021. Since then Ray Dalio bought shares two more times and sold shares on two occasions. The stake costed the investor $9.25 Million, netting the investor a gain of 49% so far.